Vazzano Joseph Walter 4
4 · ABEONA THERAPEUTICS INC. · Filed Jun 9, 2026
Research Summary
AI-generated summary of this filing
Abeona Therapeutics (ABEO) CFO Joseph Vazzano Sells Shares
What Happened
Joseph W. Vazzano, Chief Financial Officer of Abeona Therapeutics (ABEO), sold a total of 49,338 shares in open-market transactions on June 8–9, 2026. The disposals were: 10,271 shares at $5.43 ($55,766), 13,421 shares at $5.30 ($71,188), and 25,646 shares at $5.39 (~$138,288), for aggregate proceeds of roughly $265,242. These were sales (S), not purchases.
Key Details
- Transaction dates: June 8, 2026 and June 9, 2026.
- Individual trades:
- 10,271 shares @ $5.43 — ~$55,766
- 13,421 shares @ $5.30 — ~$71,188
- 25,646 shares @ $5.39 — ~$138,288
- Weighted-average price ranges reported across the multiple executions: $5.345–$5.54, $5.24–$5.47, and $5.30–$5.42 (report states weighted averages and offers to provide per-price breakdown on request).
- Footnotes: the filing says the sales were to cover tax obligations from vesting of restricted stock awards; at least one sale was executed pursuant to a Rule 10b5-1 trading plan adopted Jan 21, 2026.
- Shares owned after the transactions: not disclosed in the provided filing extract.
- Filing timeliness: Form 4 was filed on June 9, 2026 (timely with the reported transaction dates).
Context
Sales to cover tax withholding on vested awards and trades under a pre-established 10b5-1 plan are common executive transactions and are typically considered routine; they do not, by themselves, indicate a judgment about the company’s outlook.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-08$5.43/sh−10,271$55,766→ 557,504 total - Sale
Common Stock
[F1][F3]2026-06-09$5.30/sh−13,421$71,188→ 544,083 total - Sale
Common Stock
[F4][F5]2026-06-09$5.39/sh−25,646$138,288→ 518,437 total
Footnotes (5)
- [F1]The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2026.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.